Use of the 46/1 haplotype to model JAK2V617F clonal architecture in PV patients: clonal evolution and impact of IFNα treatment

被引：13
作者：
Hasan, S. [1 ,2 ,3 ]
Cassinat, B. [4 ]
Droin, N. [1 ,2 ,3 ]
Le Couedic, J. P. [1 ,2 ,3 ]
Favale, F. [1 ,2 ,3 ]
Monte-Mor, B. [1 ,2 ,3 ]
Lacout, C. [1 ,2 ,3 ]
Fontenay, M. [5 ]
Dosquet, C. [4 ]
Chomienne, C. [4 ,6 ]
Solary, E. [1 ,2 ,3 ]
Villeval, J. L. [1 ,2 ,3 ]
Casadevall, N. [1 ,7 ]
Kiladjian, J. J. [8 ]
Vainchenker, W. [1 ,2 ,3 ]
Plo, I. [1 ,2 ,3 ]
机构：
[1] INSERM, UMR 1009, Lab Excellence GR Ex, Villejuif, France
[2] Univ Paris 11, Inst Gustave Roussy, UMR 1009, Villejuif, France
[3] Inst Gustave Roussy, Villejuif, France
[4] Hop St Louis, AP HP, Serv Biol Cellulaire, Paris, France
[5] Hop Cochin, AP HP, Serv Hematol Biol, F-75674 Paris, France
[6] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France
[7] Hop St Antoine, AP HP, Hematol Lab, F-75571 Paris, France
[8] Hop St Louis, AP HP, Ctr Invest Clin, Paris, France
来源：
LEUKEMIA | 2014年 / 28卷 / 02期
关键词：
TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE NEOPLASMS; ESSENTIAL THROMBOCYTHEMIA; HEMATOPOIETIC STEM; MUTATION; DISORDERS; JAK2V617F; CELLS;
D O I：
10.1038/leu.2013.303
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：460 / 463
页数：5
相关论文
共 50 条
  • [41] FREQUENCY OF COEXISTENCE AND KINETICS OF THE BCR-ABL1 TRANSCRIPT LEVEL AND ALLELE BURDEN OF JAK2V617F AND CALR TYPE 1, 2 GENE MUTATIONS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Abdullaev, A. O.
    Stepanova, E. A.
    Makarik, T., V
    Nikulina, E. Y.
    Treglazova, S. A.
    Goryacheva, S. R.
    Shukhov, O. A.
    Bykova, A., V
    Tratsevskaya, Z., V
    Melikyan, A. L.
    Kovrigina, A. M.
    Turkina, A. G.
    Sudarikov, A. B.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2020, 65 (03): : 263 - 280
  • [42] JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival
    Tefferi, A.
    Lasho, T. L.
    Patnaik, M. M.
    Finke, C. M.
    Hussein, K.
    Hogan, W. J.
    Elliott, M. A.
    Litzow, M. R.
    Hanson, C. A.
    Pardanani, A.
    LEUKEMIA, 2010, 24 (01) : 105 - 109
  • [43] The G allele of the JAK2 rs10974944 SNP, part of JAK2 46/1 haplotype, is strongly associated with JAK2 V617F-positive myeloproliferative neoplasms
    Adrian P. Trifa
    Andrei Cucuianu
    Ljubomir Petrov
    Laura Urian
    Mariela S. Militaru
    Delia Dima
    Ioan V. Pop
    Radu A. Popp
    Annals of Hematology, 2010, 89 : 979 - 983
  • [44] Data-driven analysis of the kinetics of the JAK2V617F allele burden and blood cell counts during hydroxyurea treatment of patients with polycythemia vera, essential thrombocythemia, and primary myelofibrosis
    Dam, Marc J. B.
    Pedersen, Rasmus K.
    Knudsen, Trine A.
    Andersen, Morten
    Skov, Vibe
    Kjaer, Lasse
    Hasselbalch, Hans C.
    Ottesen, Johnny T.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (06) : 624 - 633
  • [45] Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele
    Anelli, Luisa
    Orsini, Paola
    Zagaria, Antonella
    Minervini, Angela
    Coccaro, Nicoletta
    Parciante, Elisa
    Minervini, Crescenzio Francesco
    Cumbo, Cosimo
    Tota, Giuseppina
    Impera, Luciana
    Conserva, Maria Rosa
    Redavid, Immacolata
    Tarantini, Francesco
    Ricco, Alessandra
    Attolico, Immacolata
    Specchia, Giorgina
    Albano, Francesco
    LEUKEMIA, 2021, 35 (02) : 619 - 622
  • [46] Mutation Analysis of JAK2V617F, FLT3-ITD, NPM1, and DNMT3A in Chinese Patients with Myeloproliferative Neoplasms
    Wang, Min
    He, Na
    Tian, Tian
    Liu, Lu
    Yu, Shuang
    Ma, Daoxin
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [47] Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in Polycythemia vera and contribute to the growth of clonal erythroblasts independently of JAK2V617F
    M Boissinot
    C Cleyrat
    M Vilaine
    Y Jacques
    I Corre
    S Hermouet
    Oncogene, 2011, 30 : 990 - 1001
  • [48] Molecular genetic tests for JAK2V617F, Exon12_JAK2 and MPLW515K/L are highly informative in the evaluation of patients suspected to have BCR-ABL1-negative myeloproliferative neoplasms
    dos Santos, Marcos Tadeu
    Mitne-Neto, Miguel
    Miyashiro, Kozue
    Ferrari Chauffaille, Maria de Lourdes L.
    Rizzatti, Edgar Gil
    JOURNAL OF CLINICAL PATHOLOGY, 2014, 67 (02) : 176 - 178
  • [49] TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients
    Trifa, Adrian P.
    Banescu, Claudia
    Tevet, Mihaela
    Bojan, Anca
    Dima, Delia
    Urian, Laura
    Torok-Vistai, Tunde
    Popov, Viola M.
    Zdrenghea, Mihnea
    Petrov, Ljubomir
    Vasilache, Anca
    Murat, Meilin
    Georgescu, Daniela
    Popescu, Mihaela
    Patrinoiu, Oana
    Balea, Marius
    Costache, Roxana
    Coles, Elena
    Saguna, Carmen
    Berbec, Nicoleta
    Vladareanu, Ana-Maria
    Mihaila, Romeo G.
    Bumbea, Horia
    Cucuianu, Andrei
    Popp, Radu A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (02) : 218 - 226
  • [50] Application of PRV-1 mRNA expression level and JAK2V617F mutation for the differentiating between polycytemia vera and secondary erythrocytosis and assessment of treatment by interferon or hydroxyurea
    Tutaeva, V.
    Misurin, A. V.
    Michiels, J. J.
    Rozenberg, J. M.
    Sokolova, M. A.
    Ivanova, V. L.
    Kolosheinova, T.
    Manakova, T. E.
    Levina, A. A.
    Semenova, E. A.
    Khoroshko, N. D.
    HEMATOLOGY, 2007, 12 (06) : 473 - 479
12345